Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion type Assertion NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_head.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion description "[In contrast to endometrioid carcinomas, serous cancers expressed substantially lower levels of DNMT1 and DNMT3B than normal controls, with four- and twofold reduction observed in DNMT1 and DNMT3B mRNA levels, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion evidence source_evidence_literature NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion SIO_000772 15721400 NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion wasDerivedFrom befree-2016 NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.
- NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_assertion wasGeneratedBy ECO_0000203 NP481620.RAVt1EjeHW1jTeTRZ8ThsuabgxZK4ugIr0KWAXcVfKhag130_provenance.